Breaking News

Catalent Drug Delivery Institute Names Director

February 28, 2013

Robinson has more than 20 years of experience

Terry Robinson has been appointed executive director of The Catalent Applied Drug Delivery Institute. Ms. Robinson joined Catalent in 2008 as director of Global Accounts, having previously held senior positions with large pharmaceutical companies. She has more than 20 years of experience in the pharmaceutical industry.
 
Kurt Nielsen Ph.D., senior vice president of R&D at Catalent said, “The appointment of an executive director is significant in strengthening the institute’s ability to foster better collaboration in drug development.”
 
Established in 2012, the Institute aims to accelerate the adoption of advanced drug delivery technologies through industry and academic collaboration, research and education. Earlier this year it commissioned an industry wide drug delivery survey, and has recently launched the second annual Global Academic Competition for Life Science Leaders of Tomorrow, which encourages students’ interest and knowledge of applied drug delivery technologies.
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important